抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 4-Methyl-3,17-dioxo-androsten-4 | 566-48-3 | C20H28O2 |
|
—— | [(E,2S)-5-[[(2R,5S,6S)-6-[(2E,4E)-5-[(4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate | 146478-72-0 | C27H41NO8 |
|
—— | (3R,6R,9R,15R,18R,21R,24R,30R)-30-ethyl-33-[(E,2S)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | 59865-13-3 | C62H111N11O12 |
|
—— | cyclo[Abu-Sar-D-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-N(Me)Val-N(Me)Bmt(E)] | 59865-13-3 | C62H111N11O12 |
|
—— | Trilaciclib dihydrochloride | 1977495-97-8 | C24H32Cl2N8O |
|
—— | [(2R,3S,4S,5S,6R)-6-[[(3E,5Z,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate | 873857-62-6 | C52H74Cl2O18 |
|
—— | (1R,9S,12S,13R,14S,17R,18E,21S,23S,24S,25S,27R)-12-[(E)-1-[(1R,3R,4R)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 137071-32-0 | C43H68ClNO11 |
|
—— | cyclo[Abu-Sar-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-D-N(Me)Leu-D-N(Me)Val-D-N(Me)Bmt(E)] | 59865-13-3 | C62H111N11O12 |
|
—— | cyclo[DL-Abu-Sar-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-N(Me)Val-N(Me)Bmt(E)] | 59865-13-3 | C62H111N11O12 |
|
—— | (1S,4Z,9R)-4-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione | 58735-64-1 | C22H23N5O2 |
|
—— | [(1R,2R,4S)-4-[(2S)-2-[(1R,9S,12S,15R,16Z,18S,19S,21R,23S,24E,26Z,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate | 162635-04-3 | C56H87NO16 |
|
—— | (1R,12S,13R,14S,17S,18E,21R,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 137071-32-0 | C43H68ClNO11 |
|
—— | 5-((R)-sec-Butylamino)-N1-((1R,3S,5S)-8-(5-(cyclopropanecarbonyl)pyridin-2-yl)-8-azabicyclo(3.2.1)octan-3-yl)-2-methylterephthalamide | 1149705-71-4 | C29H37N5O3 |
|
—— | Pharmakon1600-01300040 | 1716-12-7 | C10H12NaO2+ |
|
—— | Torisel (TM) | 162635-04-3 | C56H87NO16 |
|
—— | Zosuquidr.3hcl (ly335979) | 167465-36-3 | C32H32ClF2N3O2 |
|
—— | D9,11-Nimolinone | 106533-51-1 | C28H38O3 |
|
—— | Daclatasvir SRRS Isomer | 1009119-64-5 | C40H50N8O6 |
|
—— | 1H-Indole, 2-(2-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-, monomethanesulfonate | 803712-79-0 | C21H23N3O4S |
|
—— | Rebastinib tosylate | 1020172-07-9 | C37H36FN7O6S |
|
—— | Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-->5)-disulfide | 128517-07-7 | C24H36N4O6S2 |
|
—— | (4xi)-4,5-Anhydro-1,2-dideoxy-4-methyl-2-({N-[(morpholin-4-yl)acetyl]-L-alanyl-O-methyl-L-tyrosyl}amino)-1-phenyl-D-glycero-pent-3-ulose | 960374-59-8 | C31H40N4O7 |
|
—— | cis-N-((4-Cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide | 1142090-23-0 | C21H24F3N7O |
|
—— | ENMD-2076 (Tartrate) | 1291074-87-7 | C25H31N7O6 |
|
—— | 201677-61-4 | C20H24N2NaO8S |
|
|
—— | 1028486-06-7 | C27H20ClFN4NaO4 |
|
|
—— | N1-pyrrolidine-N5-(4-trifluoromethoxy)phenylbiguanide acetate | 1422365-94-3 | C2H4O2*C13H16F3N5O |
|
—— | sabutoclax | 1228108-65-3 | C42H40N2O8 |
|
—— | Champix | 375815-87-5 | C17H19N3O6 |
|
—— | 2(1H)-Pyrimidinone, 1-beta-D-ribofuranosyl- | 3690-10-6 | C9H12N2O5 |
|
—— | methyl (4aS,6aR,6bS,12aS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | 218600-53-4 | C32H43NO4 |
|
—— | evacetrapib | 1186486-62-3 | C31H36F6N6O2 |
|
—— | cyclo[Abu-Sar-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-DL-N(Me)Val-N(Me)Bmt(E)] | 59865-13-3 | C62H111N11O12 |
|
—— | N-[(3S,6R,12R,15S,16S,19S,22S,25S)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide | 120138-50-3 | C53H67N9O10S |
|
—— | (4aS,6aR,6bS,8aR,12aS,14bS)-Methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate | 218600-53-4 | C32H43NO4 |
|
—— | (27S)-22-ethyl-7,11,15-trihydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione | 11052-72-5 | C45H74O10 |
|
—— | (1R)-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 104987-11-3 | C44H69NO12 |
|
—— | N-(4-(2,4-dimethylphenyl)thiazol-2-yl)benzamide hydrochloride | 313553-47-8 | C18H17ClN2OS |
|
—— | CYP3cide | 1390637-82-7 | C26H32N8 |
|
—— | Deutivacaftor | 1413431-07-8 | C24H28N2O3 |
|
—— | (1R,9S,12S,13S,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 104987-11-3 | C44H69NO12 |
|
—— | Deuruxolitinib | 1513883-39-0 | C17H18N6 |
|
—— | (18E)-12-[(E)-1-(4-chloro-3-methoxycyclohexyl)prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 137071-32-0 | C43H68ClNO11 |
|
—— | cyclosporin A | 59865-13-3 | C62H111N11O12 |
|
—— | amonafide malate | 618863-54-0 | C4H6O5*C16H17N3O2 |
|
—— | (4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate | 1256565-36-2 | C25H20Cl2N2O3 |
|
—— | 4-[(2S)-2-amino-2-carboxyethyl]-N,N-bis(2-chloroethyl)benzeneamine oxide;hydrochloride | 685898-44-6 | C13H19Cl3N2O3 |
|
—— | linsitinib | 867160-72-3 | C26H23N5O |
|
—— | EPZ5676 | 1380288-87-8 | C30H42N8O3 |
|
—— | (E)-N’-(1-(pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide | 71555-25-4 | C11H14N4S |
|